Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
Ryan M Barber, Reed J D Sorensen, David M. Pigott, et al.
The Lancet (2022) Vol. 399, Iss. 10344, pp. 2351-2380
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Alize J Ferrari, Damian Santomauro, Amirali Aali, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2133-2161
Open Access | Times Cited: 1214
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Mohsen Naghavi, Kanyin Liane Ong, Amirali Aali, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2100-2132
Open Access | Times Cited: 727
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
Sarah Wulf Hanson, Cristiana Abbafati, Joachim G.J.V. Aerts, et al.
JAMA (2022) Vol. 328, Iss. 16, pp. 1604-1604
Open Access | Times Cited: 662
The Global Burden of Disease Study at 30 years
Christopher J L Murray
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2019-2026
Open Access | Times Cited: 393
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021
Thomas J. Bollyky, Erin Hulland, Ryan M Barber, et al.
The Lancet (2022) Vol. 399, Iss. 10334, pp. 1489-1512
Open Access | Times Cited: 360
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, et al.
The Lancet (2023) Vol. 401, Iss. 10379, pp. 833-842
Open Access | Times Cited: 322
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
Zhujun Cao, Weiyi Gao, Hong Bao, et al.
New England Journal of Medicine (2022) Vol. 388, Iss. 5, pp. 406-417
Open Access | Times Cited: 194
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Houriiyah Tegally, James Emmanuel San, Matthew Cotten, et al.
Science (2022) Vol. 378, Iss. 6615
Open Access | Times Cited: 120
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 99
A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
Sarah Wulf Hanson, Cristiana Abbafati, Joachim G.J.V. Aerts, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 73
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 48
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Jorge R Ledesma, Jianing Ma, Meixin Zhang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. 698-725
Open Access | Times Cited: 38
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Richard Furie, Brad H. Rovin, Jay Garg, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 12
Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis
Christopher S. von Bartheld, Lingchen Wang
Cells (2023) Vol. 12, Iss. 3, pp. 430-430
Open Access | Times Cited: 42
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
Timothy A. Bates, Hans C. Leier, Savannah K. McBride, et al.
JCI Insight (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 41
Disinfectants against SARS-CoV-2: A Review
Shuqi Xiao, Zhiming Yuan, Yi Huang
Viruses (2022) Vol. 14, Iss. 8, pp. 1721-1721
Open Access | Times Cited: 39
Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa
Bavesh D Kana, Patrick Arbuthnot, Benjamin K Botwe, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 8, pp. e288-e300
Open Access | Times Cited: 23
Estatística Cardiovascular – Brasil 2023
Gláucia Maria Moraes de Oliveira, Luísa Campos Caldeira Brant, Carísi Anne Polanczyk, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 2
Open Access | Times Cited: 16
Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
Jianyi Wei, Shupeng Liu, Yuexiang Bian, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Prediction of COVID-19 mortality using machine learning strategies and a large-scale panel of plasma inflammatory proteins: A cohort study
Luiz Filipe Bastos Mendes, Henrique Ritter Dal-Pizzol, Gabriele da Silveira Prestes, et al.
Medicina Intensiva (English Edition) (2025), pp. 502200-502200
Closed Access | Times Cited: 1
Pseudo-Label Guided Image Synthesis for Semi-Supervised COVID-19 Pneumonia Infection Segmentation
Fei Lyu, Mang Ye, Jonathan Frederik Carlsen, et al.
IEEE Transactions on Medical Imaging (2022) Vol. 42, Iss. 3, pp. 797-809
Closed Access | Times Cited: 35
Estimates of excess mortality for the five Nordic countries during the COVID-19 pandemic 2020−2021
Kasper P. Kepp, Jonas Björk, Vasilis Kontis, et al.
International Journal of Epidemiology (2022) Vol. 51, Iss. 6, pp. 1722-1732
Open Access | Times Cited: 30
Evaluation of the Global Health Security Index as a predictor of COVID-19 excess mortality standardised for under-reporting and age structure
Jorge R Ledesma, Christopher R. Isaac, Scott F. Dowell, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012203-e012203
Open Access | Times Cited: 22
Endemic characteristics of SARS-CoV-2 infection
Igor Nesteruk
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top